Liu Z, Wang H, Larsen M, Gunewardana S, Cendali FI, Reisz JA, et al
In response to comments that suggested CMS acquire more data before determining whether the eCQM/MIPS CQM reporting incentive is duplicative with the health equity adjustment, we discussed earlier in this section of the final rule that performance year 2024 ACO quality results have become available since the publication of the CY 2026 PFS proposed rule
As weve learned, optimizing B12 therapy means looking at each patients unique needs
[29] Glutathione facilitates metabolism of xenobiotics
Trial REIMAGINE 2 Phase 3 Duration Reported 2026 Population (N) Adults with T2D Key Result Sponsor reported HbA1c reduction of 1.91 percentage points and 14.2% weight loss
Patients who complete two or three cycles consistently report that the improvement between cycles two and three is greater than the improvement between baseline and cycle one